Back
Cerevel Therapeutics Holdings Vs. Bristol-Myers Squibb Industry Stock Comparison
Buy
53
CERE
Cerevel Therapeutics Holdings
Last Price:
42.16
Seasonality Move:
21.35%
Sell
38
BMY
Bristol-Myers Squibb
Last Price:
44.93
Seasonality Move:
0.31%
Buy
53
Cerevel Therapeutics Holdings (CERE)
is a Buy
Is Cerevel Therapeutics Holdings a Buy, Sell or Hold?
- The current Cerevel Therapeutics Holdings [CERE] share price is $42.30. The Score for CERE is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- CERE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
38
Bristol-Myers Squibb (BMY)
is a Sell
Is Bristol-Myers Squibb a Buy, Sell or Hold?
- The current Bristol-Myers Squibb [BMY] share price is $44.74. The Score for BMY is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- BMY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CERE Stock Price Chart
What is Cerevel Therapeutics Holdings's stock price today?
-
The Cerevel Therapeutics Holdings share price today is $42.30
The current trend is moderately bearish and CERE is experiencing buying pressure, which is a positive indicator for future bullish movement.
BMY Stock Price Chart
What is Bristol-Myers Squibb's stock price today?
-
The Bristol-Myers Squibb share price today is $44.74
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMY is experiencing buying pressure, which is a positive indicator for future bullish movement.
CERE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 51.71 | Buy |
| Chaikin Money Flow: | 980887 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.84 - 42.52) | Buy |
| Bollinger Bands (100): | (41.52 - 42.56) | Buy |
BMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.76 | Sell |
| Relative Strength Index (14 RSI): | 35.65 | Sell |
| Chaikin Money Flow: | 9487664 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.38 - 49.78) | Sell |
| Bollinger Bands (100): | (47.54 - 52.62) | Sell |
CERE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.45 | Sell |
| 20-day SMA: | 42.19 | Buy |
| 50-day SMA: | 42.06 | Buy |
| 200-day SMA: | 33.44 | Buy |
| 8-day EMA: | 42.34 | Sell |
| 20-day EMA: | 42.28 | Buy |
| 50-day EMA: | 41.91 | Buy |
| 200-day EMA: | 36.59 | Buy |
BMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.02 | Buy |
| 20-day SMA: | 46.17 | Sell |
| 50-day SMA: | 49.77 | Sell |
| 200-day SMA: | 53.25 | Sell |
| 8-day EMA: | 44.46 | Buy |
| 20-day EMA: | 46.06 | Sell |
| 50-day EMA: | 48.35 | Sell |
| 200-day EMA: | 53.52 | Sell |
Cerevel Therapeutics Holdings Earnings Growth & CERE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and a decrease next year of $0.32 per share.
Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, an increase next quarter of $0.22 per share, a decrease this year of $6.86 per share, and an increase next year of $6.41 per share.
Cerevel Therapeutics Holdings Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bristol-Myers Squibb Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||